Alveolar Soft Part Sarcoma Overview
Learn About Alveolar Soft Part Sarcoma
- Alveolar soft part sarcoma
- ASPS
University Health System, Inc.
James Lewis is a Surgical Oncologist in Knoxville, Tennessee. Dr. Lewis and is rated as an Advanced provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Melanoma, Rhabdomyosarcoma Embryonal, Epithelioid Sarcoma, and Mesenchymoma. Dr. Lewis is currently accepting new patients.
University Health System, Inc.
Timothy Panella is an Oncologist and a Hematologist in Knoxville, Tennessee. Dr. Panella and is rated as an Experienced provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Melanoma, Breast Cancer, Paget Disease of the Breast, and Polymorphous Low Grade Adenocarcinoma. Dr. Panella is currently accepting new patients.
University Health System, Inc.
Larry Kilgore is a Gynecologic Oncologist and an Oncologist in Knoxville, Tennessee. Dr. Kilgore and is rated as an Experienced provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Endometrial Cancer, Ovarian Cancer, Desmoplastic Small Round Cell Tumor, and Malignant Mixed Mullerian Tumor. Dr. Kilgore is currently accepting new patients.
Background: A type of drug called monoclonal antibody immune checkpoint inhibitors are often used in cancer treatment. These drugs help the body s immune system fight cancer by blocking proteins that cause cancer cells to grow. One of these drugs (atezolizumab) is approved to treat certain cancers. Researchers want to find out if lower doses of this drug might provide the same benefit with fewer adverse effec...
Summary: This phase II trial tests whether atezolizumab alone or in combination with selinexor works to shrink tumors in patients with alveolar soft part sarcoma and whether the study drugs are better than the usual approach in treating this type of cancer. The usual approach is defined as care most people get for alveolar soft part sarcoma if they are not part of a clinical study, which includes treatment...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center